Transcenta Therapeutics logo

Transcenta Therapeutics Employee Directory

Biotechnology ResearchFlorida, United States51-200 Employees

Transcenta Therapeutics is a clinical-stage biopharmaceutical company focused on antibody-based therapeutics, integrating discovery, development, and manufacturing capabilities. It has a global footprint spanning China and the United States, with a headquarters and discovery, clinical, and translational research center in Suzhou, a manufacturing facility in Hangzhou, clinical development centers in Beijing, Shanghai, and Guangzhou, and a presence in Princeton, United States. The company is advancing nine therapeutic antibody molecules for oncology and selected non-oncology indications, including bone and kidney disorders. It listed on the Main Board of the Hong Kong Stock Exchange in September 2021. In 2026, Transcenta appointed Christopher Hwang as Head of Global Partnerships for its Highly Intensified Continuous Bioprocessing platform.

Find Transcenta Therapeutics employees' phone numbers or email addresses

Transcenta Therapeutics Global Highlights

Location
Employees

North America
71

Minus sign iconPlus sign icon
  • United States Of America
    71

Asia
52

Minus sign iconPlus sign icon
  • China
    51
  • Indonesia
    1

Europe
3

Minus sign iconPlus sign icon
  • Serbia
    2
  • Spain
    1

Oceania
1

Minus sign iconPlus sign icon
  • New Zealand
    1

Transcenta Therapeutics's Leadership

  • Head Of Translational Science Operation at Transcenta Therapeutics
    A. L.
    Head Of Translational Science Operation
  • Head Of Information Technology at Transcenta Therapeutics
    R. L.
    Head Of Information Technology
  • Sr. Director Of Corporate Communications& Ea To Chairman & Ceo at Transcenta Therapeutics
    B. C.
    Sr. Director Of Corporate Communications& Ea To Chairman & Ceo
  • Partner at Transcenta Therapeutics
    A. L.
    Partner
  • Senior Vice President Of Capital Markets, Investor Relations And Corporate Communications at Transcenta Therapeutics
    T. M.
    Senior Vice President Of Capital Markets, Investor Relations And Corporate Communications
  • Executive Vice President, Global Product Development at Transcenta Therapeutics
    C. Q.
    Executive Vice President, Global Product Development
  • Svp at Transcenta Therapeutics
    S. Y.
    Svp
  • Vp,corporate Operation & Program Management at Transcenta Therapeutics
    K. Y.
    Vp,corporate Operation & Program Management

Transcenta Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Administrative
  • Human Resources
  • Biotechnology
  • Business Development
  • Other
  • Community & Social Services
  • Branding

Contact profiles from Transcenta Therapeutics

Name
Title
Contact
Location
Last Update
  • Sr. Director Of Corporate Communications& Ea To Chairman & Ceo at Transcenta Therapeutics
    B. C.
    Sr. Director Of Corporate Communications& Ea To Chairman & Ceo
    China, Zhejiang
    Jul 24, 2026
  • Partner at Transcenta Therapeutics
    A. L.
    Partner
    Aug 02, 2024
  • Senior Vice President Of Capital Markets, Investor Relations And Corporate Communications at Transcenta Therapeutics
    T. M.
    Senior Vice President Of Capital Markets, Investor Relations And Corporate Communications
    Spain, Madrid
    Sep 01, 2026
  • Executive Vice President, Global Product Development at Transcenta Therapeutics
    C. Q.
    Executive Vice President, Global Product Development
    China
    Aug 18, 2026
  • Head Of Translational Science Operation at Transcenta Therapeutics
    A. L.
    Head Of Translational Science Operation
    China, Jiangsu
    Mar 24, 2026
  • Head Of Information Technology at Transcenta Therapeutics
    R. L.
    Head Of Information Technology
    China, Jiangsu
    Aug 29, 2026
  • Svp at Transcenta Therapeutics
    S. Y.
    Svp
    China
    Jul 24, 2026
  • Vp,corporate Operation & Program Management at Transcenta Therapeutics
    K. Y.
    Vp,corporate Operation & Program Management
    China, Shanghai
    Sep 09, 2026
  • Associate Director Clinical Operations - Us at Transcenta Therapeutics
    E. J.
    Associate Director Clinical Operations - Us
    Aug 18, 2026
  • Sr Hr Director at Transcenta Therapeutics
    H. Z.
    Sr Hr Director
    China, Jiangsu
    Aug 18, 2026

Frequently Asked Questions

What is Transcenta Therapeutics known for?

Minus sign iconPlus sign icon
Transcenta Therapeutics operates in the Biotechnology Research industry. Explore Transcenta Therapeutics's company overview page for more information.

What is Transcenta Therapeutics's most common email format?

Minus sign iconPlus sign icon
Transcenta Therapeutics employees' email format typically follows the pattern of First.Last@transcenta.com. Trying to find reliable and up-to-date employee contact data? Find more Transcenta Therapeutics email formats with LeadIQ.

How many employees does Transcenta Therapeutics have currently?

Minus sign iconPlus sign icon
Transcenta Therapeutics has approximately 88 employees as of August 2026. These team members are located across 4 continents, including North America, Asia and Europe.

Who are Transcenta Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Transcenta Therapeutics's key employees include:

  • Head Of Translational Science Operation: A. L.
  • Head Of Information Technology: R. L.
  • Sr. Director Of Corporate Communications& Ea To Chairman & Ceo: B. C.
  • Partner: A. L.
  • Senior Vice President Of Capital Markets, Investor Relations And Corporate Communications: T. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.